Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Sino Biopharmaceutical Limited    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
05/16/2019 05/17/2019 05/20/2019 05/21/2019 05/22/2019 Date
8.13 7.88 7.82 7.66 7.7 Last
125012325 50613571 61448698 49500989 56832316 Volume
+5.86% -3.08% -0.76% -2.05% +0.52% Change
Financials (CNY)
Sales 2019 23 459 M
EBIT 2019 5 608 M
Net income 2019 3 150 M
Finance 2019 6 843 M
Yield 2019 0,91%
Sales 2020 26 260 M
EBIT 2020 6 474 M
Net income 2020 3 617 M
Finance 2020 9 437 M
Yield 2020 0,99%
P/E ratio 2019 26,98
P/E ratio 2020 23,62
EV / Sales2019 3,34x
EV / Sales2020 2,89x
Capitalization 85 216 M
More Financials
Company
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of... 
Sector
Pharmaceuticals
Calendar
05/21Earnings Release
More about the company
Surperformance© ratings of Sino Biopharmaceutical Lim
Trading Rating : Investor Rating :
More Ratings
Latest news on SINO BIOPHARMACEUTICAL LIM
05/22SINO BIOPHARMACEUTICAL : Biopharm 1Q net up 11.1% to RMB856.7 million
AQ
05/21SINO BIOPHARMACEUTICAL : Announces 2019 First Quarterly Results
AQ
05/20ASIA MARKETS: Asian Markets Mixed As Investors Weigh Huawei Implications
DJ
05/10SINO BIOPHARMACEUTICAL : Biopharm gets drug registration approval
AQ
04/25SINO BIOPHARMACEUTICAL : Biopharm Fudosteine tablet passes evaluation
AQ
04/16ASIA MARKETS: Asian Markets Little Changed As China's Economy Holds Steady
DJ
04/02SINO BIOPHARMACEUTICAL : Biopharm year net up 317% to RMB9.05bn
AQ
04/01SINO BIOPHARMACEUTICAL : 2018 Annual Results Reaches New Height
AQ
03/19ASIA MARKETS: Asian Markets Muted, Awaiting Upcoming Fed Meeting
DJ
03/01ASIA MARKETS: Asian Markets Climb On Trade-deal Hopes, MSCI Expansion
DJ
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIM
More recommendations
Sector news : Pharmaceuticals - NEC
01:04aDAIICHI SANKYO : looking to sell OTC drug unit for about $900 million - Nikkei B..
RE
05/22JOHNSON & JOHNSON : J&J Unit Gets FDA Priority Review of Invokana in Chronic Kid..
DJ
05/22Synlogic to Study SYNB1891 With Roche's Tecentriq in Advanced Solid Tumors
DJ
05/22AMGEN : to Buy Danish Biotech Nuevolution for $167 Million
DJ
05/22SANOFI : French Deal Spree Fueled By Easy Money
DJ
More sector news : Pharmaceuticals - NEC
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO BIOPHARMACEUTICAL LIM
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 7,79  CNY
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Ping Tse Chief Executive Officer & Executive Director
Y Y Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Hsin Tse Executive Director & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
SINO BIOPHARMACEUTICAL LIMITED48.94%12 552
JOHNSON & JOHNSON7.03%367 513
PFIZER-4.54%231 237
ROCHE HOLDING LTD.9.70%226 519
NOVARTIS12.54%207 417
MERCK AND COMPANY4.04%203 088